Cara Therapeutic Stock Cycle Indicators Hilbert Transform Dominant Cycle Period

CARA Stock  USD 0.30  0.01  3.45%   
Cara Therapeutic cycle indicators tool provides the execution environment for running the Hilbert Transform Dominant Cycle Period indicator and other technical functions against Cara Therapeutic. Cara Therapeutic value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of cycle indicators indicators. As with most other technical indicators, the Hilbert Transform Dominant Cycle Period indicator function is designed to identify and follow existing trends. Cycle Indicators are used by chartists in order to analyze variations of the instantaneous phase or amplitude of Cara Therapeutic price series.

Indicator
The output start index for this execution was thirty-two with a total number of output elements of twenty-nine. The Hilbert Transform - Dominant Cycle Period indicator is used to generate in-phase and quadrature components of Cara Therapeutic price series in order to analyze variations of the instantaneous cycles.

Cara Therapeutic Technical Analysis Modules

Most technical analysis of Cara Therapeutic help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Cara from various momentum indicators to cycle indicators. When you analyze Cara charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cara Therapeutic Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Cara Therapeutic. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cara Therapeutic based on widely used predictive technical indicators. In general, we focus on analyzing Cara Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cara Therapeutic's daily price indicators and compare them against related drivers, such as cycle indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Cara Therapeutic's intrinsic value. In addition to deriving basic predictive indicators for Cara Therapeutic, we also check how macroeconomic factors affect Cara Therapeutic price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding18.2638.8269.9366.43
PTB Ratio2.723.630.70.67
Hype
Prediction
LowEstimatedHigh
0.020.304.68
Details
Intrinsic
Valuation
LowRealHigh
0.193.798.17
Details
Naive
Forecast
LowNextHigh
0.010.264.64
Details
4 Analysts
Consensus
LowTargetHigh
13.0014.2915.86
Details

Become your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Did you try this?

Run Portfolio Optimization Now

   

Portfolio Optimization

Compute new portfolio that will generate highest expected return given your specified tolerance for risk
All  Next Launch Module

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Macroaxis Index Idea
Macroaxis Index
Invested few shares
Adviser Favorites Idea
Adviser Favorites
Invested few shares
Blockchain Idea
Blockchain
Invested few shares
Investor Favorites Idea
Investor Favorites
Invested few shares
Dividend Beast Idea
Dividend Beast
Invested over 50 shares
Momentum Idea
Momentum
Invested over 60 shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Power Assets Idea
Power Assets
Invested over 200 shares
Hedge Favorites Idea
Hedge Favorites
Invested few shares
Banking Idea
Banking
Invested over 40 shares
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
Social Domain Idea
Social Domain
Invested few shares
When determining whether Cara Therapeutic offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cara Therapeutic's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cara Therapeutic Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cara Therapeutic Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cara Therapeutic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
For information on how to trade Cara Stock refer to our How to Trade Cara Stock guide.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cara Therapeutic. If investors know Cara will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cara Therapeutic listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.75)
Revenue Per Share
0.202
Quarterly Revenue Growth
(0.86)
Return On Assets
(0.63)
Return On Equity
(1.84)
The market value of Cara Therapeutic is measured differently than its book value, which is the value of Cara that is recorded on the company's balance sheet. Investors also form their own opinion of Cara Therapeutic's value that differs from its market value or its book value, called intrinsic value, which is Cara Therapeutic's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cara Therapeutic's market value can be influenced by many factors that don't directly affect Cara Therapeutic's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cara Therapeutic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cara Therapeutic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cara Therapeutic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.